Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 3/20 | 0.44 |
| ▸ | CA4 | P22748 | 2/20 | 0.44 |
| ▸ | CES2 | O00748 | 3/20 | 0.42 |
| ▸ | CES1 | P23141 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | ALPL | P05186 | 1/20 | 0.33 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.32 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18697369 | 0.85 | CA1 (0.44) | CA1CA2CA4CES2CES1 | |
| SCHEMBL1994881 | 0.83 | CA1 (0.43) | CA1CA2CA4CES2CES1 | |
| SCHEMBL26770524 | 0.83 | CA1 (0.43) | CA1CA2CA4CES2CES1 | |
| SCHEMBL15033733 | 0.82 | MAPT (0.36) | CA1CA2CA4CES2CES1 | |
| SCHEMBL27110084 | 0.81 | CA1 (0.41) | CA1CA2CA4CES2CES1 | |
| SCHEMBL17740107 | 0.81 | CA1 (0.41) | CA1CA2CA4CES2CES1 | |
| SCHEMBL14563139 | 0.79 | CES2 (0.43) | CA1CA2CA4CES2CES1 | |
| SCHEMBL22381463 | 0.79 | CA1 (0.40) | CA1CA2CA4CES2CES1 | |
| SCHEMBL15763915 | 0.79 | MAPT (0.43) | CA1CA2CA4CES2CES1 | |
| SCHEMBL29319716 | 0.79 | CES2 (0.34) | CA1CA2CA4CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3626701-B1 | FLUORINATED CARBONATE DERIVATIVE PRODUCTION METHOD | UNIV KOBE NAT UNIV CORP (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-11167259-B2 | Fluorinated carbonate derivative production method | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2021-11-09 | — | — | US | disclosed |
| US-11167259-B2 | Fluorinated carbonate derivative production method | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2021-11-09 | — | — | US | disclosed |
| US-20200122114-A1 | FLUORINATED CARBONATE DERIVATIVE PRODUCTION METHOD | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2020-04-23 | — | — | US | disclosed |
| US-20200122114-A1 | FLUORINATED CARBONATE DERIVATIVE PRODUCTION METHOD | NATIONAL UNIVERSITY CORPORATION KOBE UNIVERSITY (JP) | 2020-04-23 | — | — | US | disclosed |
| EP-3626701-A1 | FLUORINATED CARBONATE DERIVATIVE PRODUCTION METHOD | National University Corporation Kobe University (JP) | 2020-03-25 | — | — | EP | disclosed |
| CN-110719904-A | Process for producing fluorinated carbonate derivative | 国立大学法人神户大学 | 2020-01-21 | — | — | CN | disclosed |
| US-10377847-B2 | Strong reversible hydrogels | SUPRAPOLIX B.V. (NL) | 2019-08-13 | — | — | US | disclosed |
| EP-2343342-B1 | STRONG REVERSIBLE HYDROGELS | SUPRAPOLIX BV (NL) | 2015-09-16 | — | — | EP | disclosed |
| US-20140128482-A1 | STRONG REVERSIBLE HYDROGELS | SUPRAPOLIX B.V. (NL) | 2014-05-08 | — | — | US | disclosed |
| US-8628789-B2 | Strong reversible hydrogels | SUPRAPOLIX, B.V. (NL) | 2014-01-14 | — | — | US | disclosed |
| EP-2343342-A1 | Strong reversible hydrogels | SupraPolix B.V. (NL) | 2011-07-13 | — | — | EP | disclosed |
| EP-1972661-B1 | Strong reversible hydrogels | SUPRAPOLIX BV (NL) | 2011-07-06 | — | — | EP | disclosed |
| US-20080260795-A1 | STRONG REVERSIBLE HYDROGELS | SUPRAPOLIX B.V. | 2008-10-23 | — | — | US | disclosed |
| EP-1972661-A1 | Strong reversible hydrogels | SupraPolix B.V. (NL) | 2008-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10377847-B2 | Strong reversible hydrogels | HSPA4L, H1-4, CD44 | CA1 4260/4885CA2 4259/4885CA4 3759/4885 |
| US-11167259-B2 | Fluorinated carbonate derivative production method | CA4, CA3, CA14 | CA1 9/4885CA2 5/4885CA4 1/4885 |
| US-20200122114-A1 | FLUORINATED CARBONATE DERIVATIVE PRODUCTION METHOD | CA4, CA3, CA14 | CA1 9/4885CA2 5/4885CA4 1/4885 |
| US-20080260795-A1 | STRONG REVERSIBLE HYDROGELS | HSPA4L, H1-4, CD44 | CA1 4260/4885CA2 4259/4885CA4 3759/4885 |
| US-20140128482-A1 | STRONG REVERSIBLE HYDROGELS | HSPA4L, H1-4, CD44 | CA1 4260/4885CA2 4259/4885CA4 3759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.